Table 4.
Women’s Odds Ratio Comparing the Prevalence of Increased Inflammatory Marker Between Subjects with Overweight, Obese and Morbid Obesity and Subjects with Normal BMI
| Inflammation Factors | Body Mass Index Category (kg/m2) | ||
|---|---|---|---|
| 25–<30 | 30–<35 | ≥35 | |
| WBC > 10 (103 per cubic mm) | |||
| Crude | 1.6 (1.0–2.5) | 2.6 (1.5–4.5) | 4.7 (2.5–8.8) |
| Model 1 | 1.8 (1.1–2.8) | 3.0 (1.7–5.3) | 5.3 (2.8–10.1) |
| Model 2 | 1.8 (1.1–2.8) | 2.8 (1.6–5.0) | 4.7 (2.4–9.1) |
| Thrombocytes > 400 (103 per cubic mm) | |||
| Crude | 1.5 (0.8–2.9) | 3.7 (1.8–7.6) | 2.1 (0.6–7.1) |
| Model 1 | 1.6 (0.8–3.1) | 4.0 (1.9–8.3) | 2.2 (0.6–7.6) |
| Model 2 | 1.5 (0.8–3.0) | 3.9 (1.8–8.2) | 2.0 (0.6–7.2) |
| ESR >20 (mm/hour) | |||
| Crude | 1.9 (1.6–2.2) | 2.8 (2.2–3.5) | 8.8 (3.4–7.0) |
| Model 1 | 1.8 (1.5–2.1) | 2.6 (2.0–3.3) | 4.6 (3.2–6.6) |
| Model 2 | 1.8 (1.5–2.1) | 2.6 (2.0–3.3) | 4.6 (3.2–6.6) |
| CRP > 0.5 mg/dl | |||
| Crude | 2.1 (1.6–2.6) | 4.9 (3.7–6.5) | 16.4 (11.3–24.1) |
| Model 1 | 1.9 (1.5–2.4) | 4.4 (3.4–5.5) | 14.4 (10.7–19.2) |
| Model 2 | 2.3 (1.9–3.0) | 5.9 (4.4–7.9) | 19.2 (12.9–28.6) |